NLRB Blocks New Organization's Attempts to Divide UHW; SEIU UHW Committed to Securing Good Contracts Wi... ( OAKLAND Calif. Feb. 22 -- Statement ...)

NLRB Blocks New Organization's Attempts to Divide UHW; SEIU UHW Committed to Securing Good Contracts With Members

Date:2/21/2009

OAKLAND, Calif., Feb. 22 /PRNewswire-USNewswire/ -- Statement of Eliseo Medina and David Regan, Trustees of SEIU UHW, after it was revealed in BNA's Daily Labor Report that the National Labor Relations Board has blocked the attempts of Sal Rosselli and other former officers of UHW to weaken their former local. The NLRB also announced its intent to investigate charges of Unfair Labor Practices after learning that the ousted leaders of UHW had failed to bargain and close contracts for workers:

"At a time when California and this nation face extreme economic uncertainty, SEIU has real strength in numbers. As the largest union in California, we can amplify our voice and use our resources to fight back against cutbacks and shrinkage.

"SEIU UHW has a proud history of negotiating strong contracts that raise standards for our members and ensure health and other benefits. The best way to guarantee that this tradition continues is to make certain that pending contracts are negotiated with member leaders and finalized with the rank-and-file's support.

"For union members to secure strong contracts, workers must be represented fairly and union officials must bargain in good faith. That's the law. But too many of UHW's members now are working under open contracts -- some open for more than 8 months -- because their former leaders failed in their duty to represent the members of this union by allowing contract negotiations to languish.

"As trustees of UHW, we commit to the members of this local that we will work with the member leaders of UHW to secure good contracts for the thousands of workers who do some of the toughest jobs out there. Together, we will face the economic challenges before us and improve the lives of California healthcare workers."

SOURCE SEIU UHW
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Post Your Comments:

(Date:12/15/2009)... Dec. 15 Accelify is proud to announce ... of Advisors. David will serve as Director of Development ... Accelify,s National Board of Advisors. ,, David ... District,s Board of Education in June 1995. As the ... of over 600,000 stretching from Northeast Los Angeles through ...

(Date:12/15/2009)... Reportlinker.com announces that a ... in its catalogue: ,, The ... Market Forecasts to 2015, Competitive Benchmarking, ... ,, http://www.reportlinker.com/p0168098/The-Future-of-Cardiovascular-Diseases-Therapeutics---Market-Forecasts-to-2015-Competitive-Benchmarking-Product-Pipeline-and-Deals-Analysis.html ,, ... released its latest research "The Future ...

(Date:12/15/2009)... CHENNAI, India, Dec. 15 Hospira, ... world leader in generic injectable pharmaceuticals, and ... NSE: ORCHIDCHEM), a leading Indian pharmaceuticals company ... manufacturers globally, today announced an agreement for ... form pharmaceuticals business for approximately $400 million. ...

(Date:12/15/2009)... to a gynaecologist or midwife are generally associated ... could offer so much more. Women, doctors and ... opportunities for dialogue about sexual health, reveals a ... of Gothenburg, Sweden. , Many young women see ... 500 women aged 23-29 answered questions about their ...

(Date:12/15/2009)... 2009) Although seen as a potential heart ... inhibiting activity of a transfer protein may not be ... Mayer USDA Human Nutrition Research Center on Aging (USDA ... of Medicine found an association between low plasma cholesterol ... heart disease in the Framingham Heart Study population. , ...

[0] Accelify Announces the Addition of David Tokofsky to its National Board of Advisors [0] Reportlinker Adds The Future of Cardiovascular Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis [0] Hospira to Acquire Orchid's Generic Injectable Pharmaceuticals Business [0] More about sex and relationships needed at gynecological visits [0] Low cholesterol transfer protein activity associated with heart disease risk

... the,number of visitors to Internet drug outlets nearly tripling ... higher than ever. Based on its,assessment of more than ... of Boards of Pharmacy(R) (NABP(R)) finds,that 97% of these ... state,and federal laws or established patient safety and pharmacy ...

... Halloween can be,filled with tricks and treats but ... Poison Control System (CPCS) urges parents to take,safety precautions ... If parents have questions, the CPCS is available ... for immediate expert help and information in,case of poison ...

... LifeSync Corporation,announced it has entered into a Group ... members in 20 states, for the sale of ... Shelley Hartman, President of LifeSync Corp., said, ... MAGNET. MAGNET is a major supply chain,leader and ...

... (NYSE: RMD ),announced today that on Thursday, November ... quarter of fiscal year 2009, ended September 30,2008. ResMed ... Pacific,Time and will host a conference call to review ... conference call is scheduled to begin at 1:30 p.m. ...

... Oct. 22 Every year in Jacksonville,nearly 600 ... until now,their long road to recovery lacked long-term ... Clubhouse, the only program,in Florida created to help ... to community reintegration., The Brain Injury Association ...

... Dr. Polk is a world-renowned surgeon, researcher, administrator, and,Chair ... WASHINGTON, Oct. 22 The Foundation for,Biomedical Research ... Dr. Hiram C. Polk Jr. as chairman of the ... who was FBR,s chairman for,nearly 25 years., "I ...

Other Medicine News:Health News:NABP Findings Underscore Dangers of Purchasing Prescription Medicine Online and From Foreign Sources 2 Health News:NABP Findings Underscore Dangers of Purchasing Prescription Medicine Online and From Foreign Sources 3 Health News:Celebrate Halloween Safely This Year With Tips From the California Poison Control System 2 Health News:ResMed to Webcast First Quarter 2009 Earnings Conference Call 2 Health News:Brooks Rehabilitation Opens First Work-Based Brain Injury Rehab Program in Florida 2 Health News:The Foundation for Biomedical Research Names Dr. Hiram C. Polk Jr. Chairman of its Board of Governors 2

NABP Findings Underscore Dangers of Purchasing Prescription Medicine Online and From Foreign Sources Celebrate Halloween Safely This Year With Tips From the California Poison Control System LifeSync Corporation Signs MAGNET Contract ResMed to Webcast First Quarter 2009 Earnings Conference Call Brooks Rehabilitation Opens First Work-Based Brain Injury Rehab Program in Florida The Foundation for Biomedical Research Names Dr. Hiram C. Polk Jr. Chairman of its Board of Governors

(Date:12/15/2009)... SAN DIEGO, Dec. 15 Safe ... to developing novel technologies that prevent the spread ... is ramping production of its comfortable, breathable, A400 ... agencies address the global shortage of N95 respirators ... manufacturing capacity in response to a rapid rise ...

(Date:12/15/2009)... ALTO, Calif., Dec. 15 Varian Medical Systems ... will report results for first quarter of fiscal year ... January 27, 2010. The news release will be ... at 2:00 p.m. PT. The news release and ... available on the company website at: www.varian.com/investor . ...

(Date:12/15/2009)... IRVINE, Calif., Dec. 15 Masimo (Nasdaq: ... and Measure-Through Motion and Low Perfusion pulse oximetry, ... Kiani has been awarded the 2009 Frost & ... North American Patient Monitoring market. According to Frost ... of Mr. Kiani,s "unprecedented ability in understanding customer ...

Breaking Medicine Technology:Safe Life Ramps Production Capacity of Comfortable, Breathable N95 Respirator Amid Worldwide Shortage 2 Safe Life Ramps Production Capacity of Comfortable, Breathable N95 Respirator Amid Worldwide Shortage 3 Safe Life Ramps Production Capacity of Comfortable, Breathable N95 Respirator Amid Worldwide Shortage 4 Varian Medical Systems Schedules First Quarter FY2010 News Release and Conference Call 2 Masimo Chairman and CEO Joe Kiani Receives 2009 Frost & Sullivan CEO of the Year Award 2 Masimo Chairman and CEO Joe Kiani Receives 2009 Frost & Sullivan CEO of the Year Award 3 Masimo Chairman and CEO Joe Kiani Receives 2009 Frost & Sullivan CEO of the Year Award 4 Masimo Chairman and CEO Joe Kiani Receives 2009 Frost & Sullivan CEO of the Year Award 5 Masimo Chairman and CEO Joe Kiani Receives 2009 Frost & Sullivan CEO of the Year Award 6 Prodrug could help curb skin toxicity related to EGFR inhibiting cancer drugs 55918 1 Prodrug could help curb skin toxicity related to EGFR inhibiting cancer drugs 55918 2 Breast cancer 3A Risk increases for smokers and overweight women 55914 1 Breast cancer 3A Risk increases for smokers and overweight women 55914 2 Eatin 28not so 29 good in the neighborhood 9757 1 Eatin 28not so 29 good in the neighborhood 9757 2

[0] Safe Life Ramps Production Capacity of Comfortable, Breathable N95 Respirator Amid Worldwide Shortage [0] Varian Medical Systems Schedules First Quarter FY2010 News Release and Conference Call [0] Masimo Chairman and CEO Joe Kiani Receives 2009 Frost & Sullivan CEO of the Year Award

... Introgen Therapeutics, Inc.,(NASDAQ: INGN) and the Company's ... demonstrating a significant,correlation between abnormal p53, tumor ... patients with recurrent,squamous cell carcinoma of the ... presented today at the annual meeting of ...

... of Phase 2 Clinical Data Published at ... Meeting, CHICAGO, June 04, 2007 /PRNewswire-FirstCall/ -- ... Phase II,multi-center clinical study of Amrubicin, the ... treatment of small cell lung cancer. These ...

Other Medicine Technology:Introgen Reports Updated Phase 2 Advexin Data Correlating Improved,Survival, Tumor Responses and Predictive p53 Biomarker 2 Introgen Reports Updated Phase 2 Advexin Data Correlating Improved,Survival, Tumor Responses and Predictive p53 Biomarker 3 Introgen Reports Updated Phase 2 Advexin Data Correlating Improved,Survival, Tumor Responses and Predictive p53 Biomarker 4 Pharmion's Amrubicin Shows Encouraging Results Compared to Standard,of Care in Second Line Treatment of Small Cell Lung Cancer 2 Pharmion's Amrubicin Shows Encouraging Results Compared to Standard,of Care in Second Line Treatment of Small Cell Lung Cancer 3 Pharmion's Amrubicin Shows Encouraging Results Compared to Standard,of Care in Second Line Treatment of Small Cell Lung Cancer 4

Introgen Reports Updated Phase 2 Advexin Data Correlating Improved,Survival, Tumor Responses and Predictive p53 Biomarker Pharmion's Amrubicin Shows Encouraging Results Compared to Standard,of Care in Second Line Treatment of Small Cell Lung Cancer

... leader in liquid handling, we are proud ... pipette that combines simplicity, comfort and functionality ... on the results of recent independent ergonomics ... Novus gives you the power to reach ...

... The PFA-100 In Vitro Diagnostic System aids ... It is the first commercially available in ... vivo function of platelets in primary hemostasis. ... shear conditions similar to the environment of ...

... Compact is a system that measures ... samples. This rate may be relevant ... The sedimentation rate is measured in ... typically used in high-volume settings such ...

... complete range of automatic systems for performing ... mL of blood. With the introduction of ... clinical diagnostic market a truly revolutionary testing ... limitation associated with the traditional ESR techique.,By ...

Medicine Products:

Finnpipette Novus PFA-100 System StaRRsed Compact Automatic ESR Analyzer Ves-matic 20

NLRB Blocks New Organization's Attempts to Divide UHW; SEIU UHW Committed to Securing Good Contracts Wi...( OAKLAND Calif. Feb. 22 -- Statement ...),Health